Tumor‐Resident Microbiota‐Based Risk Model Predicts Neoadjuvant Therapy Response of Locally Advanced Esophageal Squamous Cell Carcinoma Patients
Abstract
Research context
OpenAlex topics: Esophageal Cancer Research and Treatment · Pancreatic and Hepatic Oncology Research · Gastric Cancer Management and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oncology & Cancer Institute Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu Sichuan 610072 P. R. China
Sichuan Cancer Hospital & Institute Sichuan Cancer Center School of Medicine University of Electronic Science and Technology of China Chengdu Sichuan 610041 P. R. China
Jinfeng Laboratory Chongqing 400039 P. R. China
Yu‐Yue Pathology Scientific Research Center Chongqing 400039 P. R. China
Thoracic Surgery Department The First Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong 510230 P. R. China
Department of Oncology West China School of Public Health and West China Fourth Hospital Sichuan University Chengdu Sichuan 610041 P. R. China
Institute of Pathology and Southwest Cancer Center Ministry of Education of China Southwest Hospital Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology Chongqing 400038 P. R. China
Acupuncture and Massage College Chengdu University of Traditional Chinese Medicine Chengdu Sichuan 610072 P. R. China
Funding
National Key Research and Development Program of China Stem Cell and Translational Research · National Natural Science Foundation of China